Michael Steinberg MD

Proud to share the SS25 UCLA Radiation Oncology Journal. This issue features Francesco Clemente. Richard Deming and his book, This Exquisite Loneliness. Leanne Ford as our Featured Designer. And Yale Younger, Richard Siken as our Featured Poet. tinyurl.com/UCLA-RO

A new study led by @AmarUKishan Read more: uclahealth.org/news/release/h…

Proud to share that UCLA Radiation Oncology is now in El Segundo. uclahealth.org/news/article/n…

UCLA Radiation Oncology's Dr. @DrewMoghanaki emphasizes the national importance of lung cancer screening to the @nytimes in reference to a recent JAMA publication from scientists at the American Cancer Society. Read the piece here: archive.is/IHOyy

#LungCancer screening saves lives — but current criteria miss nearly half of future cases. Dr. Drew Moghanaki explains why change is needed. More from @nytimes: nyti.ms/487lYco

🫁 I’m proud to be at an institution that keeps our patients informed about the most important issues. @dramycummings @AshleyEProsper

A new @JAMAOnc study co-led by @AmarUKishan suggests shorter courses of androgen deprivation therapy may reduce risks while maintaining effective cancer control. bit.ly/487Aelm

My first #ASTRO as @UCLA faculty. What an enjoyable time with my rad onc family! Leaving the Bay inspired and optimistic for the future of cancer care

Congratulations to @AmarUKishan on receiving the 2025 Steven A. Leibel Memorial Award, one of the highest honors in radiation oncology, presented by @ASTRO_org and @ABR_Radiology. bit.ly/3ILwltS

@UCLA Rad Onc residents locking in on their research at #ASTRO2025 🤩 so proud! Highlights from Mon feat. PGY5 Travis Courtney, PGY3s Nic Nelson and Mimi Lane, and former resident (now @StanfordRadOnc faculty) Beth Neilsen.

New 4-year results from the SCIMITAR trial, led by @AmarUKishan & @MSteinbergMD and published in @EUplatinum, show that SBRT after prostate surgery is safe, effective & comparable to standard radiation. bit.ly/4gOisrg

Congratulations to @DrewMoghanaki on this well-deserved recognition!

@JesusJ_MD presenting 4-year outcomes of post-op SBRT on the phase II SCIMITAR trial — in press soon!

Don't miss @TrudyWuMD at #ASTRO25 moderating a panel on using digital tools to make cancer education more understandable. Experts and a patient advocate share strategies, videos & resources to help empower patients in their cancer journey. Learn more: bit.ly/46K1Cq5

Just in from #ASTRO25: @AmarUKishan & @CalaisJeremie report adding PSMA-targeted radioligand therapy before SBRT more than doubled progression-free survival in men with recurrent prostate cancer (17.6 vs 7.4 months), delaying the need for hormone therapy. bit.ly/4mAuZzV

Don’t miss Dr. Jonathan Massachi at #ASTRO25 sharing MIRAGE trial results on sexual function in men receiving SBRT for prostate cancer, comparing CT-guided vs MRI-guided treatment. Learn more: bit.ly/3KcuNtc

This morning at #ASTRO25, Dr. Travis Courtney will discuss research that compares the side effects of standard high-dose MRgSBRT with an adaptive dose-painted approach that boosts radiation to tumor areas while sparing surrounding tissue. Learn more: bit.ly/3KdBpHO

Today, Dr. Miriam Lane will present new findings at #ASTRO25 on postoperative SBRT for patients with newly diagnosed or recurrent head and neck cancer. Learn more: bit.ly/42zGxw9

Today at #ASTRO25: Dr. Daniel Low, a UCLA professor of radiation oncology, will present results from the first large study of 5DCT, a new imaging technique that enhances scans for lung cancer patients with irregular breathing patterns. Learn more: bit.ly/46ccZqL

Congrats to @AmarUKishan & team on receiving a $2M grant to advance MRI-guided radiotherapy. The funding will help open new trials using this technology to treat prostate, gastrointestinal, gynecological cancers, and sarcomas. Learn more: bit.ly/3IhCu0M